Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease
| Status: | Enrolling by invitation |
|---|---|
| Conditions: | Renal Impairment / Chronic Kidney Disease |
| Therapuetic Areas: | Nephrology / Urology |
| Healthy: | No |
| Age Range: | 15 - 45 |
| Updated: | 4/21/2016 |
| Start Date: | September 1999 |
| End Date: | May 2016 |
Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) II
The Division of Kidney Urology and Hematology Disease (DKUHD) of the National Institute of
Diabetes and Digestive and Kidney Diseases (NIDDK) funded a cooperative agreement (UO1) for
a consortium of participating clinical centers (PCCs) and a data coordinating and imaging
analysis center (DCIAC) to develop and implement studies to test whether imaging techniques
can provide accurate and reproducible markers of progression of renal disease in patients
with polycystic kidney disease.
The awarded participating clinical centers are Emory University, University of Kansas, and
Mayo Foundation (with a subcontract to the University of Alabama). The awarded DCIAC is
Washington University in St. Louis. Due to the relocation of the DCIAC P.I. from Washington
University to the University of Pittsburgh, the DCIAC for CRISP II is located at the
University of Pittsburgh.
Diabetes and Digestive and Kidney Diseases (NIDDK) funded a cooperative agreement (UO1) for
a consortium of participating clinical centers (PCCs) and a data coordinating and imaging
analysis center (DCIAC) to develop and implement studies to test whether imaging techniques
can provide accurate and reproducible markers of progression of renal disease in patients
with polycystic kidney disease.
The awarded participating clinical centers are Emory University, University of Kansas, and
Mayo Foundation (with a subcontract to the University of Alabama). The awarded DCIAC is
Washington University in St. Louis. Due to the relocation of the DCIAC P.I. from Washington
University to the University of Pittsburgh, the DCIAC for CRISP II is located at the
University of Pittsburgh.
The goal of the CRISP Study is to conduct a prospective, longitudinal trial to evaluate the
accuracy and validity of magnetic resonance imaging to determine disease progression in
ADPKD defined as a change in both renal and renal cyst volumes and renal function over time.
accuracy and validity of magnetic resonance imaging to determine disease progression in
ADPKD defined as a change in both renal and renal cyst volumes and renal function over time.
Inclusion Criteria:
1. CRISP I participants will be invited to participate in CRISP II. At entry into CRISP I
participants met a number of inclusion and exclusion criteria.
Exclusion Criteria:
1. Current psychiatric or addiction or non-compliance disorder that in the discretion of
the principal investigator indicates that the subject will not successfully complete
the study;
2. Current medical problem that in the discretion of the principal investigator would
make unsafe the participation in the study;
3. Inability to provide written informed consent
We found this trial at
5
sites
University of Alabama at Birmingham The University of Alabama at Birmingham (UAB) traces its roots...
Click here to add this to my saved trials
Emory University Emory University, recognized internationally for its outstanding liberal artscolleges, graduate and professional schools,...
Click here to add this to my saved trials
University of Pittsburgh The University of Pittsburgh is a state-related research university, founded as the...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials